These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


75 related items for PubMed ID: 11363837

  • 1. Nelfinavir (Viracept) expanded access announced.
    AIDS Treat News; 1996 Sep 20; (No 255):4. PubMed ID: 11363837
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Agouron protease inhibitor AG1343: activity reported.
    James JS.
    AIDS Treat News; 1995 May 05; (no 222):6. PubMed ID: 11362464
    [Abstract] [Full Text] [Related]

  • 4. Agouron protease inhibitor.
    AIDS Treat News; 1995 Sep 29; (no 231):5. PubMed ID: 11362869
    [Abstract] [Full Text] [Related]

  • 5. Nelfinavir access in Canada.
    TreatmentUpdate; 1998 Sep 29; 10(7):6, 8. PubMed ID: 11365783
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nelfinavir (Viracept) moves up the ranks.
    Grodeck B.
    Posit Aware; 1997 Sep 29; 8(2):16-7. PubMed ID: 11364452
    [Abstract] [Full Text] [Related]

  • 10. Nelfinavir (Viracept) approved: fourth protease inhibitor available.
    James JS.
    AIDS Treat News; 1997 Mar 21; (No 267):1-2. PubMed ID: 11364249
    [Abstract] [Full Text] [Related]

  • 11. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug 21; 13(72):144-50. PubMed ID: 15532140
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
    Idoko JA, Akinsete L, Abalaka AD, Keshinro LB, Dutse L, Onyenekwe B, Lhekwaba A, Njoku OS, Kehinde MO, Wambebe CO.
    West Afr J Med; 2002 Aug 21; 21(2):83-6. PubMed ID: 12403023
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nelfinavir (Viracept).
    Res Initiat Treat Action; 2000 Mar 21; 6(1):30-1. PubMed ID: 11708185
    [No Abstract] [Full Text] [Related]

  • 17. Ritonavir expanded access.
    GMHC Treat Issues; 1995 Dec 21; 9(12):8. PubMed ID: 11363000
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Women's nelfinavir (Viracept) trial.
    Vazquez E.
    Posit Aware; 1997 Dec 21; 8(5):15. PubMed ID: 11364633
    [Abstract] [Full Text] [Related]

  • 20. Viracept and irregular heartbeat warning.
    Fornataro K, Jefferys R.
    Body Posit; 1999 Oct 21; 12(10):10, 12. PubMed ID: 11366874
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.